ArticleFrontiers in medicine2026
Precision hybrid technique for direct SAPIEN-3 ultra™ implantation in extensive mitral annular calcification.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mitral valve surgery in patients with extensive mitral annular calcification remains challenging. Different surgical approaches have been described: from a complete decalcification and reconstruction of the mitral annulus to other techniques where a full debridement was avoided to minimize the risk of possible peri-operative complications. In the current era of transcatheter valve implantation, the issue of mitral annulus calcification has been addressed by some with the adoption of a hybrid technique, where a transcatheter aortic valve is implanted in mitral position, during open heart surgery. This technique is emerging as a treatment option for high-risk patients although it is still an off-label procedure and needs further standardization. We describe here our surgical technique to implant a SAPIEN-3 Ultra™ in mitral position, addressing some of the key points in the surgical technique: the appropriate sizing and the phase of deployment of the prosthesis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.